1. A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutation in a large UK series.
- Author
-
Rohrer, J., Beck, J., Campbell, T., Isaacs, A., Warrington, E., Stevens, J., Revesz, T., Holton, J., Scahill, Rachael, Warren, J., Fox, N., Rossor, M., Collinge, J., and Mead, S.
- Subjects
GENETIC mutation ,GENES ,TEMPORAL lobe diseases ,UBIQUITIN ,SYMPTOMS ,PHENOTYPES - Abstract
Mutations in the progranulin gene (GRN) are a major cause of frontotemporal lobar degeneration (FTLD) with ubiquitin-positive, tau-negative inclusions (FTLD-U) but the distinguishing clinical and anatomical features of this subgroup remain unclear. In a large UK cohort of FTLD (n=227), we found 5 different frameshift and premature termination mutations likely to be causative of FTLD in 27 affected family members. A four base pair insertion mutation in GRN exon 2 comprised the majority of British cases across multiple unrelated families, although microsatellite haplotype analysis supports a recent common ancestor. Additional novel missense changes were discovered of uncertain pathogenicity but deletion of the entire gene was not detected. The age of onset of disease in GRN mutation carriers was later when compared with tau gene (MAPT) mutation carriers, and duration of disease shorter than both MAPT carriers and patients with FTLD-U without mutation. Common presenting features were a behavioural syndrome, normally dominated by apathy, and language output impairment which was either a dynamic aphasia or a progressive non-fluent aphasia. Neurological and neuropsychological assessment also suggests that parietal lobe dysfunction is a characteristic feature of GRN mutation and may differentiate this group from other patients with FTLD. MR imaging showed evidence of strikingly asymmetrical atrophy with the frontal, temporal and parietal lobes all affected. GRN carriers showed more asymmetry and more posterior involvement compared to MAPT carriers or FTLD-U without mutation. Finally, we confirmed a modifying effect of APOE genotype on clinical phenotype with later onset in the GRN carriers. [ABSTRACT FROM AUTHOR]
- Published
- 2007